A novel diagnostic model for predicting immune microenvironment subclass based on costimulatory molecules in lung squamous carcinoma
There is still no ideal predictive biomarker for immunotherapy response among patients with non-small cell lung cancer.Costimulatory molecules play a role in anti-tumor immune response.Hence, they can be a potential biomarker for immunotherapy response.The current study comprehensively investigated the expression of costimulatory molecules in lung